BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20524276)

  • 1. An analysis of the OPTN/UNOS Liver Transplant Registry.
    Waki K; Tamura S; Sugawara Y; Yamashiki N; Kadowaki T; Kokudo N
    Clin Transpl; 2009; ():55-64. PubMed ID: 20524276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the OPTN/UNOS Liver Transplant Registry.
    Futagawa Y; Terasaki PI
    Clin Transpl; 2004; ():315-29. PubMed ID: 16704160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The OPTN/UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.
    Locke JE; Warren DS; Singer AL; Segev DL; Simpkins CE; Maley WR; Montgomery RA; Danovitch G; Cameron AM
    Transplantation; 2008 Apr; 85(7):935-42. PubMed ID: 18408571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
    Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
    Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.
    Kremers WK; van IJperen M; Kim WR; Freeman RB; Harper AM; Kamath PS; Wiesner RH
    Hepatology; 2004 Mar; 39(3):764-9. PubMed ID: 14999695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 1999; ():23-34. PubMed ID: 11038623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of liver transplant survival rates from the UNOS registry.
    Goh A
    Clin Transpl; 2008; ():19-34. PubMed ID: 19711511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Split-liver transplantation in the high-MELD adult patient: are we being too cautious?
    Nadalin S; Schaffer R; Fruehauf N
    Transpl Int; 2009 Jul; 22(7):702-6. PubMed ID: 19254241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELD and prediction of post-liver transplantation survival.
    Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO
    Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreas transplantation in the United States as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry.
    Sutherland DE; Gruessner A
    Clin Transpl; 1995; ():49-67. PubMed ID: 8794254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent liver transplant survival rates under the MELD/PELD system.
    Freeman RB; Harper A; Edwards EB
    Transplant Proc; 2005 Mar; 37(2):585-8. PubMed ID: 15848465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.